Phibro Animal Health Corp (FRA:PB8)
€ 23.8 1.8 (8.18%) Market Cap: 952.18 Mil Enterprise Value: 1.35 Bil PE Ratio: 59.42 PB Ratio: 4.00 GF Score: 72/100

Phibro Animal Health Corp at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 08:05PM GMT
Release Date Price: €18.39 (-1.08%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Good afternoon, everyone. Thank you for joining the session with Phibro. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And it's very much my pleasure to welcome the leadership team of the company here today.

So Jack Bendheim is immediately to my left. He is the company's Chairman and CEO, and he has been with the company, I guess, since 1988. So a very long time in the industry and has built the company and continues to grow the company globally over many years. Dick Johnson is the company's CFO. He's also been with Phibro long time, since 2002. And Donny Bendheim at the end of the row here is Executive Vice President of Corporate Strategy and has held a variety of operational and leadership roles since joining the company in 1997. So thanks for being here today, appreciate it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot